share_log
Breakings ·  Nov 5, 2024 20:00
Intra-Cellular Therapies Inc - Primary Endpoint Shows Longer Time to Relapse With Lumateperone
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment